Literature DB >> 8215023

The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders.

M E Lewis1, J L Vaught, N T Neff, P E Grebow, K V Callison, E Yu, P C Contreras, F Baldino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8215023     DOI： 10.1111/j.1749-6632.1993.tb26218.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

Review 1.  Motor neuron disease: etiology, pathogenesis and treatment--a review.

Authors:  D J Donohoe; B Brady
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

2.  Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis.

Authors:  S Ono; J Hu; T Imai; N Shimizu; M Tsumura; H Nakagawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

3.  Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy.

Authors:  T Bordet; H Schmalbruch; B Pettmann; A Hagege; L Castelnau-Ptakhine; A Kahn; G Haase
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  A role for insulin-like growth factor-I in the regulation of Schwann cell survival.

Authors:  D E Syroid; T S Zorick; C Arbet-Engels; T J Kilpatrick; W Eckhart; G Lemke
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

5.  Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.

Authors:  Erlick A C Pereira; Martin R Turner; John A H Wass; Kevin Talbot
Journal:  Amyotroph Lateral Scler       Date:  2010

6.  Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.

Authors:  P Caroni; C Schneider; M C Kiefer; J Zapf
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.